Recall: Sun Pharma Vecuronium Bromide For Injection
On 2019-01-07, the FDA announced that Sun Pharmaceutical Industries is conducting a recall on Vecuronium Bromide For Injection due to a possible particulate matter. The recalled products were sold under the brand name(s) Sun Pharma during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 2 drugs recalls due to potential particulate matter, including prednisolone and gatifloxacin ophthalmic solution, naloxone hydrochloride injection, usp, carpuject single-use cartridge syringe system and more. Additionally, there have been 20 drug and medical device recalls due to other health hazards as well as 91 food recalls.
Company Contact Information:
Name: Sun Pharmaceutical Industries
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Vecuronium Bromide for Injection
Brand Name(s): Sun Pharma
Reason for Recall: Particulate Matter
Official Recall Date: 2019-01-07
Additional information provided by the FDA.gov:
Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries, Ltd. is voluntarily recalling three lots of Vecuronium Bromide for Injection, 10 mg (lyophilized powder), and one lot of Vecuronium Bromide for Injection, 20 mg (lyophilized powder) to the hospital level. The Vecuronium Bromide for Injection has been found to contain particulate matter identified as glass. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.